Febuxostat Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets
Available Strengths: 40 mg, 80 mg
Reference Brands: Uloric(EU & US)
Category:
Arthritis
Febuxostat inhibits xanthine oxidase, reducing uric acid production. It effectively lowers serum uric acid levels, preventing gout attacks and urate crystal formation. Benefits include improved uricemia management, decreased gout flare frequency, and enhanced quality of life with a favorable safety profile when used appropriately.
Febuxostat tablets is available in Oral Tablets
and strengths such as 40 mg, 80 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Febuxostat tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Febuxostat tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Febuxostat tablets are approved in the EU and US for managing hyperuricemia and gout. In the EU, brands like Uloric (by Takeda) are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval relies on extensive clinical data and biosimilarity evaluations. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for febuxostat tablets, ensuring adherence to European and American standards, helping you navigate complex regulatory landscapes seamlessly for safe, effective gout management.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing